Vox Markets Logo
Join

View From Vox

Metals One begins exploration in earnest at Squaw Creek uranium project

Metals One begins exploration in earnest at Squaw Creek uranium project

1 month ago

Metals One has now deployed a team on the ground at Squaw Creek in Wyoming to undertake the initial stages of an extensive exploration programme

Polarean Imaging Plc – Final Results and Strategic Update (FY 2024)

Polarean Imaging Plc – Final Results and Strategic Update (FY 2024)

3 months ago

Polarean Imaging grew revenue to $3.1m in 2024, beating expectations, driven by rising use of its Xenon MRI tech. Strategic funding and partnerships support growth, while FDA progress and a pending paediatric label expansion could boost its market. Academic funding cuts may delay sales, but full-year guidance is unchanged.

Predator Oil & Gas Stays the Course Amid Trinidad Delays and Moroccan Momentum

Predator Oil & Gas Stays the Course Amid Trinidad Delays and Moroccan Momentum

3 months ago

Predator Oil & Gas (LSE: PRD) has issued a broad operational update covering its portfolio in Trinidad, Morocco and Ireland, with an emphasis on near-term production gains and strategic optionality across its assets. While the company has encountered delays in finalising its Trinidad acquisition, operational progress continues on multiple fronts.

Mindflair Secures £2.6 Million from Getvisibility Investment Exit

Mindflair Secures £2.6 Million from Getvisibility Investment Exit

5 months ago

Mindflair plc, an investor in next-generation AI technology, has agreed to sell its entire directly held minority stake in cybersecurity firm Getvisibility to Forcepoint, a global data and cloud security leader. The transaction will generate a gross cash inflow of approximately €2.1 million (£1.8 million) for Mindflair.

Polarean Imaging Expands Xenon MRI Platform for Pharma-Sponsored Research

5 months ago

Polarean Imaging has expanded its Xenon MRI imaging platform to support pharmaceutical-sponsored clinical trials, securing a collaboration with a leading global pharmaceutical company for a multicenter study on an investigational lung therapy.

Helix Exploration PLC - Advancing Towards Helium Production

6 months ago

Helix Exploration PLC has provided an operational update on its activities at the Rudyard Project, showcasing progress towards becoming a key helium producer in Montana's promising helium fairway. The company has made significant strides with the acquisition of the Xebec PSA Processing Plant now complete, following a $500,000 payment.

GSTechnologies Accelerates Digital Asset Strategy with Bake Platform Acquisition

7 months ago

GSTechnologies Limited, a fintech-focused company, has successfully completed its acquisition of the CAKE businesses, including the Bake Cryptocurrency Platform. This platform is a retail-oriented digital asset investment service that features staking, swaps, and fiat-to-crypto solutions. Key details include:

Roquefort Therapeutics in $10M Deal with Pleiades Pharma

7 months ago

Roquefort Therapeutics plc (LSE:ROQ) has announced a term sheet for the sale of its wholly owned subsidiary, Lyramid Pty Ltd, to Pleiades Pharma Limited for a minimum consideration of US$10 million. This includes equity in Pleiades and potential upfront cash payments. The transaction is expected to conclude within 30 days, subject to specific conditions such as Pleiades finalising its fundraising and in-licensing deals.

Merit Group – Trading Update Summary

9 months ago

Merit Group, a data and intelligence business, provided a trading update for the six months ended 30 September 2024 (H1) and the expected performance for the full financial year ending 31 March 2025 (FY25).

The curious case of the underperforming gold equities: is the mother of all re-ratings now due?

over 1 year ago

Gold equities are lagging gold, and severely. But why? And will it change?

View from Vox: London, we have a problem

over 1 year ago

A wave of delistings reflects mounting concerns that the London market is broken beyond repair – but is doom and gloom entirely warranted?

Vox Screens Stocks: John & Justin pick from a small cap dividends screen

2 years ago

Vox Screens Stocks: John & Justin pick from a small cap dividends screen. The criteria these companies fits are: Maximum market capitalisation of £250m, dividend yield between 4% - 10%, minimum dividend cover of 1.5%, minimum return on equity of 12.5% & maximum forecast P/E of 20.

View from Vox: why investors could protect profits by protecting water

2 years ago

Pollution, climate change and underinvestment in infrastructure has put the world’s prescious water supply in jeopardy – but three UK companies look well positioned to help solve the problem.

View from Vox: biotech picks and shovels offer a low-risk route into the rewards of drug discovery

2 years ago

Backing the companies selling the tools that support the drug development process offers a route into the potentially lucrative industry for more cautious investors.

View from Vox: the Budget’s high-tech vision is good news for investors

over 2 years ago

No Budget can please all of the people, but investors in high-tech industries should be salivating at the level of support provided to science and technology based industries in this one.

View from Vox: SVB collapse marks the end of the age of exuberance

over 2 years ago

Silicon Valley Bank's collapse won't break the banking system, but it is likely to definitively dampen persistent animal spirits and curb appetites for high-risk growth investing for some time

View from Vox: Construction’s infrastructure salvation

over 2 years ago

Residential construction is set to hit the buffers in 2023, but that's likely to be offset by huge infrastructure spending plans

View from Vox: whatever happened to safe as houses?

over 2 years ago

More grim news from the housing sector has put further pressure on the housebuilders – but some analysts think the bad news could now all be in the price

View from Vox: Interest rate rises are a double-edged sword for UK banks

over 2 years ago

Rising rates have boosted banks' profits, but higher bad loan provisions show they’re also putting serious pressure on their customers

Two top share picks from Midas for 2023

over 2 years ago

Highly regarded share pickers at the Midas column in Mail Online highlight two stocks for 2023. Read more here.....

Watchlist